CME GroupMEX:CME 86 5-Year Yield-on-Cost % is 5.12 as of Jul. 12, 2026, which is 23% above its 10-year median of 4.17. GuruFocus rates MEX:CME with a GF Score™ of 86/100 and a GF Value™ of MXN5,070.45 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 363 Capital Markets companies, CME Group ranks better than 69.42% on this metric.
CME Group's yield on cost for the quarter that ended in Mar. 2026 was 5.12.
The historical rank and industry rank for CME Group's 5-Year Yield-on-Cost % or its related term are showing as below:
MEX:CME'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.69 Med: 4.17 Max: 5.63
Current: 5.12
During the past 13 years, CME Group's highest Yield on Cost was 5.63. The lowest was 1.69. And the median was 4.17.
MEX:CME's 5-Year Yield-on-Cost % is ranked better than 69.42% of 363
companies
in the Capital Markets industry
Industry Median: 3.11
vs MEX:CME: 5.12
CME Group (MEX:CME) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
CME Group 5-Year Yield-on-Cost % Related Terms
MEX:CME vs MCO, ICE, NDAQ: 5-Year Yield-on-Cost % Comparison
For the Financial Data & Stock Exchanges subindustry, CME Group's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CME Group 5-Year Yield-on-Cost % vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, CME Group's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where CME Group's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of CME Group is calculated as
CME Group (MEX:CME) has a 5-Year Yield-on-Cost % of 5.12 as of Jul. 12, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on CME Group and its competitors. This is 23% above median its historical median of 4.17. Over the past decade, CME Group's 5-Year Yield-on-Cost % has ranged from 1.69 to 5.63. According to the industry distribution chart, CME Group ranks #111 out of 363 companies in the Capital Markets industry, placing it in the top 30.6%.
Is CME Group's 5-Year Yield-on-Cost % too high?
CME Group's current 5-Year Yield-on-Cost % of 5.12 is 23% above median its 10-year median of 4.17. Over the past 10 years, this metric has ranged from a low of 1.69 to a high of 5.63. The Capital Markets industry median 5-Year Yield-on-Cost % is 3.11. CME Group's value of 5.12 is 64.6% above this industry median. Based on the distribution chart, CME Group ranks #111 out of 363 companies in the Capital Markets industry, which is above the industry midpoint. Overall, CME Group has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CME Group's 5-Year Yield-on-Cost % compare to MCO and ICE?
According to the Capital Markets industry distribution chart, CME Group ranks #111 out of 363 companies for 5-Year Yield-on-Cost %. This puts CME Group in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 3.11. CME Group's value of 5.12 is 64.6% above this benchmark. Historically, CME Group's own 5-Year Yield-on-Cost % has ranged from 1.69 to 5.63 over the past decade. While the company's 10-year median is 4.17 vs. the industry median of 3.11, CME Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Capital Markets company?
The median 5-Year Yield-on-Cost % among Capital Markets companies is 3.11, based on 363 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CME Group's current 5-Year Yield-on-Cost % of 5.12 is 64.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on CME Group and its competitors. For the Capital Markets industry, the median 5-Year Yield-on-Cost % is 3.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CME Group's current 5-Year Yield-on-Cost % is 5.12, which is 23% above median its own 10-year median of 4.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CME Group stock overvalued right now?
Based on GuruFocus' analysis, CME Group (MEX:CME) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN5,070.45, compared to a current price of MXN4,246.57 — trading 16.2% below its estimated fair value. The current 5-Year Yield-on-Cost % is 5.12, which is 23% above median its 10-year median of 4.17 and 64.6% above the Capital Markets industry median of 3.11. CME Group's overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For CME Group (MEX:CME), the current 5-Year Yield-on-Cost % is 5.12 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CME Group (MEX:CME) Overvalued in 2026?
Based on GuruFocus' analysis, CME Group stock appears to be undervalued.
The current stock price of MXN4,246.57 is trading 16.2% below its estimated GF Value™ of MXN5,070.45.
GuruFocus considers CME Group to be Modestly Undervalued.
Key valuation signals for MEX:CME:
5-Year Yield-on-Cost %: 5.12 (23% above median its 10-year median of 4.17)
GF Value™: MXN5,070.45 vs. price of MXN4,246.57 (16.2% below fair value)
Industry Position: 64.6% above the Capital Markets median (#111 of 363)
No single metric tells the full story. See the MEX:CME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indexes, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
86GF Score
Get the complete analysis for MEX:CME
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:CME has been successfully added to your 